Adverse events 2.0-Let us get SERIOs: New reporting forĀ adverse event outcomes needed in the era of immunooncology.

Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, McArthur G, Moslehi JJ, Neilan TG, Ribas A, Robert C, Schadendorf D, Wolchok JD, Hauschild A
Eur J Cancer. 2019 112: 29-31

PMID: 30903870 · DOI:10.1016/j.ejca.2019.01.015

MeSH Terms (7)

Adverse Drug Reaction Reporting Systems Antineoplastic Agents Autoimmune Diseases Drug-Related Side Effects and Adverse Reactions Humans Immunotherapy Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: